Form 13-F position report

BIO-TECHNE CORP

Reported by AQR Arbitrage LLC

TECH CUSIP 09073M104 Manager CIK 0001167456

Reported 1,294,273 shares, up 532,405 (69.9%) from the prior quarter.

Reported value 73.9%; share count 69.9% vs. the prior quarter.

Added
% of reported 13F value 1.23% This manager · Q3 2026
Shares 1,294,273 Quarter-end amount reported
Reported value $93,627,709 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-06-30 53825974
2026-09-30 93627709

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for BIO-TECHNE CORP held by AQR Arbitrage LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Added 1,294,273 +532,405 (69.9%) 1.23% $93,627,709 2026-11-16
Q2 2026 New 761,868 +761,868 (0.0%) 0.77% $53,825,974 2026-08-14

Who else reported the position

683 managers reported BIO-TECHNE CORP for Q3 2026.

Managers reporting BIO-TECHNE CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 14,250,400 +224,584 0.02% $1,032,726,512 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 10,250,628 +32,070 0.02% $742,863,011 3 qtrs
HBK INVESTMENTS L P Added 7,732,128 +907,128 5.83% $560,347,316 2 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 6,348,862 -157,498 0.02% $460,102,029 3 qtrs
FIL Ltd Added 6,272,729 +6,268,781 0.32% $454,584,671 2 qtrs
STATE STREET CORPORATION Added 6,045,884 +65,514 0.01% $438,145,213 49 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 5,431,896 +80,432 0.02% $393,097,407 48 qtrs
The Goldman Sachs Group Inc Reduced 4,144,123 -3,199,201 0.03% $300,324,598 48 qtrs
MILLENNIUM MANAGEMENT LLC Added 4,091,871 +3,102,838 0.1% $296,537,891 48 qtrs
Invesco Ltd Reduced 3,775,138 -1,211,286 0.02% $273,584,252 48 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
1,294,273
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.